| 100695-6 |
Genetic disease analysis overall carrier interpretation |
Imp |
Bld/Tiss |
Pt |
Nar |
Molgen |
|
ACTIVE |
Genetic disease analysis overall carrier interpretation in Blood or Tissue by Molecular genetics method Narrative |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
100695-6 |
|
Molgen |
|
|
Both |
|
|
|
0 |
Gene dis anl carrier interp Bld/T-Imp |
|
|
|
N |
|
Blood; Dis; Diseases; Dz; Gene dis anl carrier interp; Genetics; Genomic; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Molecular genetics; Molecular pathology; MOLPATH; Narrative; PCR; Point in time; Random; Report; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 100696-4 |
CTNS related multigene analysis |
Prid |
Body fld+Ser/Plas |
Pt |
Nom |
Molgen |
|
ACTIVE |
CTNS related multigene analysis [Identifier] in Bodyfluid and Serum or Plasma by Molecular genetics method Nominal |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH.MUT |
|
100696-4 |
|
Molgen |
|
|
Both |
|
|
|
0 |
CTNS multigene anal Fld+SerPl |
|
|
|
N |
|
B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; CTNS multigene anal; Fl; Fld; Fld+SerPl; FLU; Fluid; Gene; Gene panel; Identity or presence; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Multi-gene study; Multiple-gene panel test; Nominal; PCR; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 100697-2 |
Note |
Find |
Outpatient |
Pt |
Doc |
Interventional radiology |
|
ACTIVE |
Interventional radiology Outpatient Note |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.ONTOLOGY |
|
100697-2 |
|
Interventional radiology |
|
|
Both |
|
|
|
0 |
IR OP Note |
|
|
|
N |
|
DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; IR; notes; OP; Point in time; Random; Visit note |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 100698-0 |
Social determinants of health screening report |
Find |
^Patient |
Pt |
Doc |
|
|
ACTIVE |
Social Determinants of Health screening report Document |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.MISC |
|
100698-0 |
|
|
|
|
Both |
|
|
|
0 |
SDOH screen report Doc |
|
|
|
N |
|
Asympt; Asymptomatic; DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random; Scn; SDOH screen report |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 100699-8 |
Rifabutin+Ethambutol |
Susc |
Isolate |
Pt |
OrdQn |
|
|
ACTIVE |
Rifabutin+Ethambutol [Susceptibility] |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
100699-8 |
|
|
|
|
Observation |
|
|
|
0 |
Rifabutin+Ethambutol Susc Islt |
|
|
|
N |
|
Ansamycin; ANTIBIOTIC SUSCEPTIBILITIES; AST; Etambol; Ethamb; Inagen; Islt; Isol; Myambutol; Mycobutin; Mycobutol; Olbutam; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 1007-4 |
Direct antiglobulin test.polyspecific reagent |
PrThr |
RBC |
Pt |
Ord |
|
|
ACTIVE |
Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
1007-4 |
|
|
|
|
Both |
|
|
|
0 |
DAT Poly-Sp Reag RBC Ql |
|
|
|
|
|
Antiglob; BLOOD BANK; DAGT; DAT; DAT Poly-Sp Reag; DCT; Dir; Direct antiglobulin test.non specific reagent; Direct Coomb; Direct coombs test; Erythrocytes; Hematology; Heme; Ordinal; Point in time; poly specific; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen; UniversalLabOrders |
2.73 |
1 |
|
|
|
|
|
|
|
|
|
|
Release 2.70: COMPONENT: Updated "poly specific" to one word (no space).; Previous Releases: The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 10070-1 |
S' wave duration.lead AVF |
Time |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
S' wave duration in lead AVF |
|
MIN |
DefinitionDescription |
|
|
s |
|
|
|
|
|
|
EKG.MEAS |
|
10070-1 |
|
EKG |
|
|
Observation |
|
|
|
0 |
S' wave dur L-AVF |
|
|
|
Y |
|
Cardiac; Cardio; Cardiology; Durat; ECG; EKG.MEASUREMENTS; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; S prime; S' wave dur L-AVF; S wave dur L-AVF |
2.48 |
1.0i |
|
|
|
|
|
|
|
s |
|
|
|
0 |
| 100700-4 |
Trichomonas vaginalis DNA |
PrThr |
Urethra |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Trichomonas vaginalis DNA [Presence] in Urethra by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
100700-4 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
T vaginalis DNA Urth Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital tract; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; T vaginalis; TMA; Transcription mediated amplification; Tric; Trich; Trichimoniasis; Trichomonad; Trichomonads; Trichomoniasis; Urth |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 100701-2 |
Trichomonas vaginalis rRNA |
PrThr |
Urethra |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Trichomonas vaginalis rRNA [Presence] in Urethra by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
100701-2 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
T vaginalis rRNA Urth Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Genital tract; Gen-Probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; ribosomal RNA; Screen; SDA; Strand Displacement Amplification; T vaginalis; TMA; Transcription mediated amplification; Tric; Trich; Trichimoniasis; Trichomonad; Trichomonads; Trichomoniasis; Urth |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 100702-0 |
Mycoplasma genitalium rRNA |
PrThr |
Urethra |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Mycoplasma genitalium rRNA [Presence] in Urethra by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
100702-0 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
M genitalium rRNA Urth Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Genital tract; Gen-Probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; M genitalium; M genitalium rRNA; Microbiology; Myco; Mycoplas; Mycoplasm; Mycoplasmoides genitalium; Mycoplasmosis; Mycoplsm; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; ribosomal RNA; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Urth |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 100703-8 |
Mycoplasma genitalium rRNA |
PrThr |
Urine |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Mycoplasma genitalium rRNA [Presence] in Urine by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
100703-8 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
M genitalium rRNA Ur Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Gen-Probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; M genitalium; M genitalium rRNA; Microbiology; Myco; Mycoplas; Mycoplasm; Mycoplasmoides genitalium; Mycoplasmosis; Mycoplsm; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; ribosomal RNA; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; UA; UR; Urn |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 100704-6 |
Mycoplasma genitalium rRNA |
PrThr |
Cvx |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Mycoplasma genitalium rRNA [Presence] in Cervix by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
100704-6 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
M genitalium rRNA Cvx Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cervix; DNA NUCLEIC ACID PROBE; DNA probe; Genital tract; Gen-Probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; M genitalium; M genitalium rRNA; Microbiology; Myco; Mycoplas; Mycoplasm; Mycoplasmoides genitalium; Mycoplasmosis; Mycoplsm; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; ribosomal RNA; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 100705-3 |
Mycoplasma genitalium rRNA |
PrThr |
Anorectal |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Mycoplasma genitalium rRNA [Presence] in Anorectal by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
100705-3 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
M genitalium rRNA Anorectl Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Anorectl; DNA NUCLEIC ACID PROBE; DNA probe; Gen-Probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; M genitalium; M genitalium rRNA; Microbiology; Myco; Mycoplas; Mycoplasm; Mycoplasmoides genitalium; Mycoplasmosis; Mycoplsm; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Rectum; ribosomal RNA; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 100706-1 |
Mycoplasma genitalium rRNA |
PrThr |
XXX |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Mycoplasma genitalium rRNA [Presence] in Specimen by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
100706-1 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
M genitalium rRNA Spec Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Gen-Probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; M genitalium; M genitalium rRNA; Microbiology; Misc; Miscellaneous; Myco; Mycoplas; Mycoplasm; Mycoplasmoides genitalium; Mycoplasmosis; Mycoplsm; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; ribosomal RNA; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 100707-9 |
Granulocytes |
NCnc |
Dial fld prt |
Pt |
Qn |
Automated count |
|
ACTIVE |
Granulocytes [#/volume] in Peritoneal dialysis fluid by Automated count |
|
NAM |
DefinitionDescription |
|
|
10*9/L |
|
|
|
|
|
|
HEM/BC |
|
100707-9 |
|
Automated count |
|
|
Both |
|
|
|
0 |
Granulocytes # DiafP Auto |
|
|
|
N |
|
#; ABS; absolute; absolutes; Auto; Automated detection; Cnt; Count; Count/volume; CT; Diaf; DiafP; Dialysate; Dialysis fluid; Elec; Elect; Electr; Gran; Grans; Granulocyte; Granulocytes; HEMATOLOGY/CELL COUNTS; Number concentration; Number Concentration (count/vol); Peritoneal Dialysis fluid; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.79 |
2.73 |
|
|
|
|
|
|
|
10*9/L |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: polymorphonuclear cells is an old term, and not in use anymore. Therefore the decision is to remove polymorphonyclear cells, and replace with Granulocytes; |
0 |
| 100708-7 |
Plasma cells/Leukocytes |
NFr |
Synv fld |
Pt |
Qn |
|
|
ACTIVE |
Plasma cells/Leukocytes in Synovial fluid |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
100708-7 |
|
|
|
|
Both |
|
|
|
0 |
Plasma Cells NFr Snv |
|
|
|
N |
|
Cell; Cellularity; HEMATOLOGY/CELL COUNTS; Joint aspirate; Joint fld; Joint flu; Joint fluid; Leuc; Leuk; Leukocyte; Lkcs; Myeloma cells; Number fraction; Percent; Plasmacyte; Plasmacytes; Point in time; QNT; Quan; Quant; Quantitative; Random; SF; SNV; Syn; Syn fl; Synov; Synovial fluid; WBC; WBCs; White blood cell; White blood cells |
2.79 |
2.73 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
| 100709-5 |
Hepatocellular carcinoma risk |
Score |
^Patient |
Pt |
Qn |
GAAD |
|
ACTIVE |
Hepatocellular carcinoma risk [Score] by GAAD |
|
ADD |
DefinitionDescription |
|
|
score |
|
|
|
|
|
|
CHEM |
|
100709-5 |
|
GAAD |
|
|
Both |
|
|
|
0 |
Hep Ca Risk Score Patient GAAD |
|
|
|
N |
|
Chemistry; Hep Ca Risk; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale |
2.73 |
2.73 |
|
|
|
|
|
|
|
{score} |
|
|
|
0 |
| 10071-9 |
S' wave duration.lead AVL |
Time |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
S' wave duration in lead AVL |
|
MIN |
DefinitionDescription |
|
|
s |
|
|
|
|
|
|
EKG.MEAS |
|
10071-9 |
|
EKG |
|
|
Observation |
|
|
|
0 |
S' wave dur L-AVL |
|
|
|
Y |
|
Cardiac; Cardio; Cardiology; Durat; ECG; EKG.MEASUREMENTS; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; S prime; S' wave dur L-AVL; S wave dur L-AVL |
2.48 |
1.0i |
|
|
|
|
|
|
|
s |
|
|
|
0 |
| 100710-3 |
Chlamydia trachomatis & Neisseria gonorrhoeae rRNA panel |
- |
Thrt |
Pt |
- |
Probe.amp.tar |
|
ACTIVE |
Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Throat by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.MICRO |
|
100710-3 |
|
Probe.amp.tar |
|
|
Order |
|
|
|
0 |
C trach+GC pnl Throat NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C trac; C trach; C trach+GC; C trach+GC pnl; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; CT; CT/GC; DNA NUCLEIC ACID PROBE; DNA probe; GC; Gen-Probe; Gono; Gonorrhea; LAT; LCR; LGV; Ligase chain reaction; Ligation-activated transcription; Lymphogranuloma venereum; Microbiology; N gonorrhoea; N gonorrhoeae; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; ribosomal RNA; SDA; Strand Displacement Amplification; Throat; TMA; Trachoma; Transcription mediated amplification; Upper respiratory |
2.73 |
2.73 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 100711-1 |
Borrelia burgdorferi.VlsE1+pepC10 Ab |
ACnc |
Ser |
Pt |
Qn |
IA |
|
ACTIVE |
Borrelia burgdorferi.VlsE1+pepC10 Ab [Units/volume] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
[arb'U] |
|
|
|
|
|
|
MICRO |
|
100711-1 |
|
IA |
|
|
Both |
|
|
|
0 |
B burgdor.VlsE1+pepC10 Ab Ser IA-aCnc |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; B burg; B burgdor; B burgdor.VlsE1+pepC10; B burgdorferi; Bb; Burgdorf; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Lyme; Lyme disease; Lymes; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS |
2.74 |
2.73 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
| 100712-9 |
Brexpiprazole |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Brexpiprazole [Mass/volume] in Serum or Plasma |
|
ADD |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
100712-9 |
|
|
|
|
Both |
|
|
|
0 |
Brexpiprazole SerPl-mCnc |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Rexulti; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
2.73 |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
| 100713-7 |
Cariprazine |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Cariprazine [Mass/volume] in Serum or Plasma |
|
ADD |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
100713-7 |
|
|
|
|
Both |
|
|
|
0 |
Cariprazine SerPl-mCnc |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; RGH 188; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Vraylar |
2.73 |
2.73 |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
| 100714-5 |
Guanfacine |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Guanfacine [Mass/volume] in Serum or Plasma |
|
ADD |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
100714-5 |
|
|
|
|
Both |
|
|
|
0 |
Guanfacine SerPl-mCnc |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Intuniv; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
2.73 |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
| 100715-2 |
Prothipendyl |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Prothipendyl [Mass/volume] in Serum or Plasma |
|
ADD |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
100715-2 |
|
|
|
|
Both |
|
|
|
0 |
Prothipendyl SerPl-mCnc |
|
|
|
N |
|
azaphenothiazine; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; phrenotropin; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
2.73 |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
| 100716-0 |
Prostate Specific Ag |
MCnc |
Bld.dot |
Pt |
Qn |
|
|
ACTIVE |
Prostate specific Ag [Mass/volume] in DBS |
|
ADD |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
CHEM |
|
100716-0 |
|
|
|
|
Both |
|
|
|
0 |
PSA DBS-mCnc |
|
|
|
N |
|
Antigen; Antigens; Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Kallikrein 3; Level; Mass concentration; P-30 antigen; Point in time; PS; PSA; QNT; Quan; Quant; Quantitative; Random; Seminin; Spec; Tumor marker; WB; Whole blood |
2.73 |
2.73 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
